Publication | Closed Access
Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models
18
Citations
19
References
2023
Year
MedicineAnti-tumor ResponsesPharmacologyHighly PotentImmune Checkpoint InhibitorCancer BiologyAnti-cancer AgentOncologyCell BiologyCancer ResearchTumor BiologyCancer Growth
| Year | Citations | |
|---|---|---|
Page 1
Page 1